Quarterly report · Q2
4885.TEDINET S100SLIK
Period2023-06-01 → 2023-11-30
Filed2024-01-12
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 51
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.9bn | 2023-06-01 → 2023-11-30 | Standalone | Net sales |
| Revenue | ¥6.3bn | 2022-06-01 → 2023-05-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.1bn | 2022-06-01 → 2022-11-30 | Standalone | Net sales |
| Operating income | ¥115m | 2023-06-01 → 2023-11-30 | Standalone | Operating income |
| Operating income | ¥225m | 2022-06-01 → 2022-11-30 | Standalone | Operating income |
| Ordinary income | ¥110m | 2023-06-01 → 2023-11-30 | Standalone | Ordinary income |
| Ordinary income | ¥351m | 2022-06-01 → 2023-05-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥208m | 2022-06-01 → 2022-11-30 | Standalone | Ordinary income |
| Profit before tax | ¥145m | 2023-06-01 → 2023-11-30 | Standalone | Income before income taxes |
| Profit before tax | ¥208m | 2022-06-01 → 2022-11-30 | Standalone | Income before income taxes |
| Net income | ¥93m | 2023-06-01 → 2023-11-30 | Standalone | Profit loss |
| Net income | ¥256m | 2022-06-01 → 2023-05-31 | Standalone | Net income loss (5-year summary) |
| Net income | ¥149m | 2022-06-01 → 2022-11-30 | Standalone | Profit loss |
| Total assets | ¥5.1bn | at 2023-11-30 | Standalone | Assets |
| Total assets | ¥4.9bn | at 2023-05-31 | Standalone | Assets |
| Total assets | ¥5.0bn | at 2022-11-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.1bn | at 2023-11-30 | Standalone | Liabilities |
| Total liabilities | ¥3.0bn | at 2023-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.0bn | at 2023-11-30 | Standalone | Net assets |
| Net assets / equity | ¥1.9bn | at 2023-05-31 | Standalone | Net assets |
| Net assets / equity | ¥1.8bn | at 2022-11-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2023-11-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥853m | at 2023-05-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.1bn | at 2023-11-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥853m | at 2023-05-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥765m | at 2022-11-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥865m | at 2022-05-31d | Standalone | Cash and cash equivalents |
| Operating cash flow | ¥143m | 2023-06-01 → 2023-11-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥317m | 2022-06-01 → 2023-05-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥58m | 2022-06-01 → 2022-11-30 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥115m | 2023-06-01 → 2023-11-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥162m | 2022-06-01 → 2023-05-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥69m | 2022-06-01 → 2022-11-30 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥185m | 2023-06-01 → 2023-11-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥172m | 2022-06-01 → 2023-05-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥28m | 2022-06-01 → 2022-11-30 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥23.63 | 2023-06-01 → 2023-11-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.85 | 2023-09-01 → 2023-11-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥67.94 | 2022-06-01 → 2023-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.92 | 2022-06-01 → 2022-11-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.8 | 2022-09-01 → 2022-11-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥23.16 | 2023-06-01 → 2023-11-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥64.12 | 2022-06-01 → 2023-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥38.62 | 2022-06-01 → 2022-11-30 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥19 | 2022-06-01 → 2023-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Equity ratio | 38.9% | at 2023-11-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.7% | at 2023-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.8% | at 2022-11-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 4,095,500 | at 2023-11-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2023-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2022-11-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥1.0bn |
| jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥1.0bn |
| jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segment | segment profit | 2023-06-01 → 2023-11-30 | −¥55m |
| jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥379m |
| jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥379m |
| jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segment | segment profit | 2023-06-01 → 2023-11-30 | −¥28m |
| jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥1.5bn |
| jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥1.5bn |
| jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥198m |
| —segment total | revenue | 2023-06-01 → 2023-11-30 | ¥2.9bn |
| —segment total | revenue external | 2023-06-01 → 2023-11-30 | ¥2.9bn |
| —segment total | segment profit | 2023-06-01 → 2023-11-30 | ¥115m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-06-01 → 2023-11-30 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-06-01 → 2023-11-30 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-06-01 → 2023-11-30 | ¥115m |
| jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥965m |
| jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥965m |
| jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segment | segment profit | 2022-06-01 → 2022-11-30 | −¥20m |
| jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥377m |
| jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥377m |
| jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segment | segment profit | 2022-06-01 → 2022-11-30 | −¥39m |
| jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥1.8bn |
| jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥1.8bn |
| jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥284m |
| —segment total | revenue | 2022-06-01 → 2022-11-30 | ¥3.1bn |
| —segment total | revenue external | 2022-06-01 → 2022-11-30 | ¥3.1bn |
| —segment total | segment profit | 2022-06-01 → 2022-11-30 | ¥225m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2022-11-30 | ¥3.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2022-11-30 | ¥3.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2022-11-30 | ¥225m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 517
| Item | Context | Value | Unit |
|---|---|---|---|
| Net sales | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000HealthyFoodBusinessReportableSegmentMember | 378840000 | JPY |
| Net sales | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000ChemicalProductsBusinessReportableSegmentMember | 1008354000 | JPY |
| Net sales | CurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember | 2912325000 | JPY |
| Net sales | CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | 2912325000 | JPY |
| Net sales | CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember | － | JPY |
| Net sales | CurrentYTDDuration_NonConsolidatedMember | 2912325000 | JPY |
| Operating income | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000PharmaceuticalBusinessReportableSegmentMember | 198488000 | JPY |
| Operating income | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000HealthyFoodBusinessReportableSegmentMember | -27920000 | JPY |
| Operating income | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E36350-000ChemicalProductsBusinessReportableSegmentMember | -55251000 | JPY |
| Operating income | CurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember | 115315000 | JPY |
| Operating income | CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | 115315000 | JPY |
| Operating income | CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember | － | JPY |
| Operating income | CurrentYTDDuration_NonConsolidatedMember | 115315000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の4の7第1項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)福岡財務支局長 | |
| Filing date cover page | FilingDateInstant | 2024-01-12 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第78期第2四半期(自 2023年9月1日 至 2023年11月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)室町ケミカル株式会社 | |
| Company name in english cover page | FilingDateInstant | MUROMACHI CHEMICALS INC. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 青木 淳一 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)福岡県大牟田市新勝立町一丁目38番5 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 0944-41-2131 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役 管理本部長 井内 聡 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)福岡県大牟田市新勝立町一丁目38番5 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 0944-41-2131 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役 管理本部長 井内 聡 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E36350 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 48850 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)室町ケミカル株式会社 | |
| Filer name in english | FilingDateInstant | MUROMACHI CHEMICALS INC. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | false | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Current fiscal year start date | FilingDateInstant | 2023-06-01 | |
| Current period end date | FilingDateInstant | 2023-11-30 | |
| Type of current period | FilingDateInstant | Q2 | |
| Current fiscal year end date | FilingDateInstant | 2024-05-31 | |
| Previous fiscal year start date | FilingDateInstant | 2022-06-01 | |
| Comparative period end date | FilingDateInstant | 2022-11-30 | |
| Previous fiscal year end date | FilingDateInstant | 2023-05-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |